Stay up-to-date on the latest news about pharmacy education and practice, including essential updates on AACP programs and services, through our numerous print and online communications vehicles.
The new center at the University of Wisconsin-Madison School of Pharmacy leverages clinical and transdisciplinary expertise in the emerging field of psychedelic-assisted therapy. In 2014, the University of Wisconsin–Madison campus became the site of the first Phase 1 clinical trial for psilocybin.